Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effect of a peripheral acting opioid antagonist (PAMORA) on
the disease course of patients with recurrent acute inflammation of the pancreas (acute
pancreatitis). The study will be conducted by treating outpatients suffering from recurrent
acute pancreatitis with a PAMORA (naldemedine) for 12 months.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Asbjørn Mohr Drewes
Collaborators:
Hvidovre University Hospital Karolinska University Hospital Odense University Hospital University Hospital Bispebjerg and Frederiksberg